Arch Neurol Chicago
-
Arch Neurol Chicago · Jun 1995
Randomized Controlled Trial Clinical TrialRandomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.
Free radicals may play a role in the pathogenesis of amyotrophic lateral sclerosis. ⋯ In this trial, treatment with the free radical scavenger acetylcysteine did not result in a major increase in 12-month survival or a reduction in disease progression in patients with amyotrophic lateral sclerosis.